Daniela Bianconi

433 total citations
23 papers, 306 citations indexed

About

Daniela Bianconi is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Daniela Bianconi has authored 23 papers receiving a total of 306 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 11 papers in Cancer Research and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Daniela Bianconi's work include Pancreatic and Hepatic Oncology Research (9 papers), Cancer Genomics and Diagnostics (9 papers) and Colorectal Cancer Treatments and Studies (8 papers). Daniela Bianconi is often cited by papers focused on Pancreatic and Hepatic Oncology Research (9 papers), Cancer Genomics and Diagnostics (9 papers) and Colorectal Cancer Treatments and Studies (8 papers). Daniela Bianconi collaborates with scholars based in Austria, Switzerland and Netherlands. Daniela Bianconi's co-authors include Gerald W. Prager, Matthias Unseld, Markus Kieler, Werner Scheithauer, Gabriela Kornek, Christoph Zielinski, Martin Schindl, Alexandra Kaider, Merima Herac and Leonhard Müllauer and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Daniela Bianconi

22 papers receiving 301 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniela Bianconi Austria 10 161 100 74 64 57 23 306
Shunichi Ishigami Japan 6 165 1.0× 105 1.1× 83 1.1× 41 0.6× 36 0.6× 25 343
Hiroyuki Goda Japan 13 146 0.9× 206 2.1× 81 1.1× 45 0.7× 24 0.4× 30 381
Y W Park South Korea 8 103 0.6× 134 1.3× 66 0.9× 45 0.7× 18 0.3× 9 324
Xia Ying China 10 82 0.5× 211 2.1× 71 1.0× 43 0.7× 20 0.4× 17 393
Warner Alpízar‐Alpízar Costa Rica 12 151 0.9× 85 0.8× 132 1.8× 101 1.6× 25 0.4× 26 407
Anke Van den broeck Belgium 6 285 1.8× 233 2.3× 128 1.7× 46 0.7× 22 0.4× 9 433
Sabrina Salgia United States 7 83 0.5× 114 1.1× 63 0.9× 89 1.4× 33 0.6× 21 227
Johanna Soikkeli Finland 6 133 0.8× 177 1.8× 79 1.1× 32 0.5× 101 1.8× 6 339
Youya Nakazawa Japan 8 233 1.4× 161 1.6× 45 0.6× 45 0.7× 16 0.3× 10 372
Pernille A. Usher Denmark 11 142 0.9× 152 1.5× 215 2.9× 40 0.6× 63 1.1× 14 423

Countries citing papers authored by Daniela Bianconi

Since Specialization
Citations

This map shows the geographic impact of Daniela Bianconi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniela Bianconi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniela Bianconi more than expected).

Fields of papers citing papers by Daniela Bianconi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniela Bianconi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniela Bianconi. The network helps show where Daniela Bianconi may publish in the future.

Co-authorship network of co-authors of Daniela Bianconi

This figure shows the co-authorship network connecting the top 25 collaborators of Daniela Bianconi. A scholar is included among the top collaborators of Daniela Bianconi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniela Bianconi. Daniela Bianconi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bianconi, Daniela, Elisabeth Fabian, Merima Herac, et al.. (2022). Expression of CD98hc in Pancreatic Cancer and Its Role in Cancer Cell Behavior. Journal of Cancer. 13(7). 2271–2280. 3 indexed citations
2.
Kieler, Markus, et al.. (2021). Bead-Based Isolation of Circulating Tumor DNA from Pancreatic Cancer Patients Enables High Fidelity Next Generation Sequencing. Cancer Management and Research. Volume 13. 6249–6261. 1 indexed citations
3.
4.
Prager, Gerald W., Matthias Unseld, Fredrik Waneck, et al.. (2019). Results of the extended analysis for cancer treatment (EXACT) trial: a prospective translational study evaluating individualized treatment regimens in oncology. Oncotarget. 10(9). 942–952. 9 indexed citations
5.
Kieler, Markus, Matthias Unseld, Daniela Bianconi, et al.. (2019). Interim analysis of a real-world precision medicine platform for molecular profiling of metastatic or advanced cancers: MONDTI. ESMO Open. 4(4). e000538–e000538. 6 indexed citations
6.
Kieler, Markus, Matthias Unseld, Daniela Bianconi, Werner Scheithauer, & Gerald W. Prager. (2019). Impact of new chemotherapy regimens on the treatment landscape and survival of advanced pancreatic cancer (PAC) patients (pts).. Journal of Clinical Oncology. 37(4_suppl). 403–403.
7.
Kieler, Markus, Matthias Unseld, Johann Wojta, et al.. (2018). Plasma levels of interleukin-33 and soluble suppression of tumorigenicity 2 in patients with advanced pancreatic ductal adenocarcinoma undergoing systemic chemotherapy. Medical Oncology. 36(1). 1–1. 14 indexed citations
8.
Kieler, Markus, Matthias Unseld, Daniela Bianconi, & Gerald W. Prager. (2018). Challenges and Perspectives for Immunotherapy in Adenocarcinoma of the Pancreas. Pancreas. 47(2). 142–157. 16 indexed citations
9.
Unseld, Matthias, Robert M. Mader, Lukas Baumann, et al.. (2018). Feasibility of personalized treatment concepts in gastrointestinal malignancies: Sub-group results of prospective clinical phase II trial EXACT. Chinese Journal of Cancer Research. 30(5). 508–515. 2 indexed citations
10.
Unseld, Matthias, Andreas Gleiß, Daniela Bianconi, et al.. (2018). Regorafenib therapy in metastatic colorectal cancer patients: markers and outcome in an actual clinical setting. Neoplasma. 65(4). 599–603. 4 indexed citations
11.
Unseld, Matthias, Alexander Siebenhüner, Andreas Gleiß, et al.. (2018). Optimizing Treatment Sequence for Late-line Metastatic Colorectal Cancer Patients Using Trifluridine/Tipiracil and Regorafenib. Clinical Colorectal Cancer. 17(4). 274–279. 12 indexed citations
12.
Kieler, Markus, Leonhard Müllauer, Oskar Koperek, et al.. (2018). Analysis of 10 Adrenocortical Carcinoma Patients in the Cohort of the Precision Medicine Platform MONDTI. Oncology. 94(5). 306–310. 5 indexed citations
13.
Bianconi, Daniela, Merima Herac, Daniel Spies, et al.. (2018). SERPINB7 Expression Predicts Poor Pancreatic Cancer Survival Upon Gemcitabine Treatment. Translational Oncology. 12(1). 15–23. 5 indexed citations
14.
Kieler, Markus, Matthias Unseld, Daniela Bianconi, & Gerald W. Prager. (2017). Cross-over comparison and new chemotherapy regimens in metastatic pancreatic cancer. memo - Magazine of European Medical Oncology. 10(3). 136–140. 4 indexed citations
15.
Bianconi, Daniela, Gerwin Heller, Daniel Spies, et al.. (2017). Biochemical and genetic predictors of overall survival in patients with metastatic pancreatic cancer treated with capecitabine and nab-paclitaxel. Scientific Reports. 7(1). 4851–4851. 6 indexed citations
16.
Unseld, Matthias, Andreas Gleiß, Daniela Bianconi, et al.. (2017). Soluble CD87 (s-uPAR) predicts bevacizumab-based first line treatment of metastatic colorectal cancer (mCRC): Results from a prospective multi-center study.. Journal of Clinical Oncology. 35(4_suppl). 604–604. 1 indexed citations
17.
Bianconi, Daniela, Merima Herac, Andreas Gleiß, et al.. (2016). Functional role of 4F2hc in pancreatic ductal adenocarcinoma. Annals of Oncology. 27. vi14–vi14. 1 indexed citations
18.
Bianconi, Daniela, Matthias Unseld, & Gerald W. Prager. (2016). Integrins in the Spotlight of Cancer. International Journal of Molecular Sciences. 17(12). 2037–2037. 119 indexed citations
19.
Chillà, Anastasia, Daniela Bianconi, Marina Poettler, et al.. (2015). Effects of cilengitide in osteoclast maturation and behavior. Experimental Cell Research. 337(1). 68–75. 10 indexed citations
20.
Bianconi, Daniela, Alexandra Schuler, Angelika Geroldinger, et al.. (2015). Integrin beta-3 genetic variants and risk of venous thromboembolism in colorectal cancer patients. Thrombosis Research. 136(5). 865–869. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shunichi Ishigami Breakdown of academic impact, for papers by Hiroyuki Goda Breakdown of academic impact, for papers by Y W Park Breakdown of academic impact, for papers by Xia Ying Breakdown of academic impact, for papers by Warner Alpízar‐Alpízar Breakdown of academic impact, for papers by Anke Van den broeck Breakdown of academic impact, for papers by Sabrina Salgia Breakdown of academic impact, for papers by Johanna Soikkeli Breakdown of academic impact, for papers by Youya Nakazawa Breakdown of academic impact, for papers by Pernille A. Usher
Rankless by CCL
2026